AMLN (DIABETES DRUGS) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : AMLN (DIABETES DRUGS)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: D.Right who wrote (831)	10/2/1997 2:09:00 PM
From: MulhollandDrive	of 2173

>>now the drug should move up or down on the merit of their drug pramlintide..< D. I agree with you that the JNJ announcement is a positive, sending a message that they still have faith in pramlintide. (I'm a businessperson and while not dealing with numbers remotely akin to 30M, I can assure you that JNJ is in business to make money and would certainly not be throwing "good money after bad" unless there was the potential of a marketable drug) That being said, the last report on the pramlintide trial would have certainly been enough to spook investors. I think there may be continued price appreciation, but without substantive results with the ongoing trials, I would not be looking anticpating strong move. Just my opinion, having limited knowledge in the biotech area. bp

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next